$1.065
+0.134 (+12.62%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACXP por análisis de gráficos similares
Alphio's ACXP stock price prediction model matches the current Acurx Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.08 (+0.96%). The 1-week path is $1.07 (+0.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Acurx Pharmaceuticals Inc?
Acurx Pharmaceuticals Inc (ACXP) is a good buy right now due to its recent positive developments, including a conditional FDA acceptance for its antibiotic candidate CIFBEZY and an improved cash position of $10.7 million, which supports operational funding for at least one year. The stock is currently priced at $1.065, significantly below its 52-week high of $7.54, indicating a potential for recovery. However, investors should be cautious of the company's ongoing net losses, which amounted to $2.3 million in Q2 2026, as this represents a risk to profitability.
ACXP cerró en $1.07 el Friday, tras subir +12.62%
Acurx Pharmaceuticals Inc (ACXP) last closed at $1.0650001, gaining +12.62%. These facts feed the 1-day and 1-week ACXP price prediction above.
Factores de la previsión
Los factores de la previsión de Acurx Pharmaceuticals Inc (ACXP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACXP, ordenadas por similitud.
Análisis de estacionalidad de ACXP
Historically the probability of a positive November return for ACXP is 0.00%. January offers the highest probability of a positive month at 36.07%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACXP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.46 | $0.48 | $0.57 | -54.55% |
| Dec 2026 | $0.47 | $0.51 | $0.54 | -52.11% |
En 2026, se proyecta que Acurx Pharmaceuticals Inc (ACXP) oscile entre $0.46 y $0.57.
Previsión mensual de Acurx Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Acurx Pharmaceuticals Inc promedie $0.48, con un mínimo de $0.46 y un máximo de $0.57.
En Dec de 2026, se proyecta que Acurx Pharmaceuticals Inc promedie $0.51, con un mínimo de $0.47 y un máximo de $0.54.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.